PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21881044-3	2011	Here, as one remarkable example, studies using a novel and highly selective pharmacologic inhibitor of the spleen tyrosine kinase Syk [PRT060318; 2-((1R,2S)-2-aminocyclohexylamino)-4-(m-tolylamino)pyrimidine-5-carboxamide] coupled with genetic experiments, demonstrate that Syk inhibition ameliorates both the acute and chronic responses to vascular injury without affecting hemostasis.	2-(2-aminocyclohexylamino)-4-(m-tolylamino)pyrimidine-5-carboxamide	135-144	spleen tyrosine kinase	Mus musculus	130-133	
21881044-3	2011	Here, as one remarkable example, studies using a novel and highly selective pharmacologic inhibitor of the spleen tyrosine kinase Syk [PRT060318; 2-((1R,2S)-2-aminocyclohexylamino)-4-(m-tolylamino)pyrimidine-5-carboxamide] coupled with genetic experiments, demonstrate that Syk inhibition ameliorates both the acute and chronic responses to vascular injury without affecting hemostasis.	2-(2-aminocyclohexylamino)-4-(m-tolylamino)pyrimidine-5-carboxamide	135-144	spleen tyrosine kinase	Mus musculus	274-277